Perceived stress in the time of COVID-19: the association with brooding and COVID-related rumination in adults with and without migraine.

Brooding COVID-19 COVID-related rumination Depressive rumination Migraine Perceived stress Rumination

Journal

BMC psychology
ISSN: 2050-7283
Titre abrégé: BMC Psychol
Pays: England
ID NLM: 101627676

Informations de publication

Date de publication:
30 Apr 2021
Historique:
received: 11 01 2021
accepted: 05 03 2021
entrez: 1 5 2021
pubmed: 2 5 2021
medline: 5 5 2021
Statut: epublish

Résumé

The main goal of this research was to explore whether migraineurs had a higher level of perceived stress than healthy controls during the times of the coronavirus and related restrictive measures, and to examine the relationship between different subtypes of rumination and perceived stress in these groups. We measured two facets of depressive rumination, brooding and reflection, along with rumination about the current COVID-19 situation to see whether these different subtypes of rumination explained perceived stress among migraineurs and healthy controls. Healthy adults (n = 64) and migraine patients (n = 73) filled out self-report questionnaires online. A multiple linear regression model was used to test whether depressive rumination (i.e. brooding and reflection) and COVID-related rumination explained perceived stress among adults with and without migraine during the times of COVID-19, after controlling for gender, age, migraine/control group status and migraine disability. Although we did not find any difference in the level of perceived stress among migraineurs and the control group, perceived stress was more strongly associated with brooding as well as COVID-related rumination among migraineurs than healthy controls. COVID-related rumination and brooding (but not reflection) explained the level of perceived stress after controlling for gender, age, migraine/control group status and migraine disability. The similar degree of perceived stress among migraineurs and the control group may imply that there is great variation in the personal experience of people regarding the pandemic, that may be determined by numerous other factors. Our results demonstrate that ruminating about the pandemic and related difficulties, as well as brooding (but not reflection) appear to be associated with higher level of perceived stress during the times of the coronavirus. This association was slightly stronger among migraineurs, hinting at the increased vulnerability of this patient group in stressful situations like the COVID-19 pandemic. Our results also suggest that ruminating about the pandemic and its consequences is weakly associated with trait-level depressive rumination, thus may be more contingent on specific factors.

Sections du résumé

BACKGROUND BACKGROUND
The main goal of this research was to explore whether migraineurs had a higher level of perceived stress than healthy controls during the times of the coronavirus and related restrictive measures, and to examine the relationship between different subtypes of rumination and perceived stress in these groups. We measured two facets of depressive rumination, brooding and reflection, along with rumination about the current COVID-19 situation to see whether these different subtypes of rumination explained perceived stress among migraineurs and healthy controls.
METHODS METHODS
Healthy adults (n = 64) and migraine patients (n = 73) filled out self-report questionnaires online. A multiple linear regression model was used to test whether depressive rumination (i.e. brooding and reflection) and COVID-related rumination explained perceived stress among adults with and without migraine during the times of COVID-19, after controlling for gender, age, migraine/control group status and migraine disability.
RESULTS RESULTS
Although we did not find any difference in the level of perceived stress among migraineurs and the control group, perceived stress was more strongly associated with brooding as well as COVID-related rumination among migraineurs than healthy controls. COVID-related rumination and brooding (but not reflection) explained the level of perceived stress after controlling for gender, age, migraine/control group status and migraine disability.
CONCLUSIONS CONCLUSIONS
The similar degree of perceived stress among migraineurs and the control group may imply that there is great variation in the personal experience of people regarding the pandemic, that may be determined by numerous other factors. Our results demonstrate that ruminating about the pandemic and related difficulties, as well as brooding (but not reflection) appear to be associated with higher level of perceived stress during the times of the coronavirus. This association was slightly stronger among migraineurs, hinting at the increased vulnerability of this patient group in stressful situations like the COVID-19 pandemic. Our results also suggest that ruminating about the pandemic and its consequences is weakly associated with trait-level depressive rumination, thus may be more contingent on specific factors.

Identifiants

pubmed: 33931113
doi: 10.1186/s40359-021-00549-y
pii: 10.1186/s40359-021-00549-y
pmc: PMC8085645
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

68

Références

Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1621-1623
pubmed: 32889403
Cephalalgia. 2016 Jun;36(7):692-703
pubmed: 27013237
Genes Brain Behav. 2017 Mar;16(3):384-393
pubmed: 27762084
Curr Pain Headache Rep. 2016 Jul;20(7):45
pubmed: 27215628
J Health Psychol. 2013 Dec;18(12):1617-28
pubmed: 24155195
Neuron. 2012 Jan 26;73(2):219-34
pubmed: 22284178
Cephalalgia. 2019 Oct;39(12):1577-1585
pubmed: 31450969
Headache. 2003 Mar;43(3):251-7
pubmed: 12603644
Behav Ther. 2006 Sep;37(3):269-80
pubmed: 16942978
Front Psychiatry. 2020 Aug 17;11:841
pubmed: 32973583
Cephalalgia. 2003 Jul;23(6):451-5
pubmed: 12807524
Eur J Pain. 2014 Oct;18(9):1290-7
pubmed: 24700516
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Front Psychol. 2018 Jan 26;9:37
pubmed: 29434563
Ann Indian Acad Neurol. 2020 Apr;23(Suppl 1):S33-S39
pubmed: 32419752
J Psychosom Res. 2010 Aug;69(2):211-25
pubmed: 20624521
Neurol Sci. 2020 Aug;41(8):2025-2027
pubmed: 32613542
Pain. 2020 Aug;161(8):1837-1846
pubmed: 32701843
J Gerontol B Psychol Sci Soc Sci. 2021 Jan 18;76(2):e30-e37
pubmed: 32674138
Clin Psychol Rev. 2010 Mar;30(2):217-37
pubmed: 20015584
J Abnorm Psychol. 1991 Nov;100(4):569-82
pubmed: 1757671
Front Neurol. 2020 Nov 10;11:597881
pubmed: 33240213
JAMA. 2007 Oct 10;298(14):1685-7
pubmed: 17925521
Front Public Health. 2020 Dec 09;8:560983
pubmed: 33363075
Psychoneuroendocrinology. 2006 Apr;31(3):373-87
pubmed: 16289608
Asian Nurs Res (Korean Soc Nurs Sci). 2012 Dec;6(4):121-7
pubmed: 25031113
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Int J Geriatr Psychiatry. 2020 Dec;35(12):1466-1467
pubmed: 32364283
Front Psychol. 2020 Aug 24;11:2033
pubmed: 32982846
Neurosci Biobehav Rev. 2011 Jun;35(7):1562-92
pubmed: 21145350
Neurosci Biobehav Rev. 2013 Jan;37(1):96-108
pubmed: 23127296
Headache. 2009 Oct;49(9):1378-86
pubmed: 19619238
Int J Ment Health Addict. 2020 May 15;:1-12
pubmed: 32427165
J Headache Pain. 2020 Sep 24;21(1):115
pubmed: 32972360
Neuroimage Clin. 2019;22:101790
pubmed: 31146320
Behav Res Ther. 2000 Jun;38(6):611-7
pubmed: 10846809
Psychol Health. 2016 Dec;31(12):1481-1497
pubmed: 27616579
Child Youth Serv Rev. 2020 Nov;118:105466
pubmed: 32994656
J Headache Pain. 2017 Dec;18(1):37
pubmed: 28324317
Pain. 2000 Oct;88(1):41-52
pubmed: 11098098
Int J Environ Res Public Health. 2020 Aug 31;17(17):
pubmed: 32877985
Neurologist. 2007 May;13(3):118-25
pubmed: 17495755
Brain Behav Immun. 2020 Jul;87:100-106
pubmed: 32353518
J Abnorm Psychol. 2013 May;122(2):339-52
pubmed: 23713497
Brain Behav Immun. 2020 Jul;87:40-48
pubmed: 32298802
Headache. 2014 Nov-Dec;54(10):1661-9
pubmed: 25339181
Death Stud. 2020 Sep 30;:1-10
pubmed: 32998663
Lancet Psychiatry. 2020 Mar;7(3):228-229
pubmed: 32032543
Neurology. 2000 Sep 12;55(5):629-35
pubmed: 10980724
Psychol Bull. 2016 Mar;142(3):231-259
pubmed: 26689087
Lancet Neurol. 2018 Nov;17(11):954-976
pubmed: 30353868
Int J Hypertens. 2012;2012:453465
pubmed: 22518285
Am Psychol. 2020 Aug 10;:
pubmed: 32772538
Front Psychol. 2020 Jun 23;11:1540
pubmed: 32655463

Auteurs

Lilla Nóra Kovács (LN)

Doctoral School of Psychology, ELTE, Eötvös Loránd University, Budapest, Hungary.
SE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
Institute of Psychology, ELTE, Eötvös Loránd University, Budapest, Hungary.

Dániel Baksa (D)

SE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.

Dóra Dobos (D)

SE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.

Nóra Eszlári (N)

Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.
NAP-2-SE New Antidepressant Target Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.

Kinga Gecse (K)

SE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.

Natália Kocsel (N)

Institute of Psychology, ELTE, Eötvös Loránd University, Budapest, Hungary.

Gabriella Juhász (G)

SE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.
NAP-2-SE New Antidepressant Target Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary.

Gyöngyi Kökönyei (G)

SE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary. kokonyei.gyongyi@pharma.semmelweis-univ.hu.
Institute of Psychology, ELTE, Eötvös Loránd University, Budapest, Hungary. kokonyei.gyongyi@pharma.semmelweis-univ.hu.
Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary. kokonyei.gyongyi@pharma.semmelweis-univ.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH